The Mayo Clinic in Arizona Scleroderma Service is comprised of physicians from several Mayo specialties who collaborate to provide comprehensive evaluations and organized care that improves the quality of life for those affected by scleroderma and associated disorders (such as Raynaud's phenomenon). The Scleroderma Service also conducts advanced research into new treatments and the cause of scleroderma, both the diffuse and limited/CREST forms of the illness.
Scleroderma (systemic sclerosis) is a chronic autoimmune disorder that causes the body to overproduce collagen and results in abnormal thickening and hardening of the skin. This build-up along with changes in small-sized blood vessels also caused by the illness can affect nearly any area of the body, including the skin, digestive tract, lungs, kidneys, heart and muscles.
Symptoms may include:
Scleroderma affects approximately 300,000 people in the United States alone. There is no known cure for scleroderma, but new clinical trials are in development.
Because scleroderma affects multiple organs in addition to the skin, many medical and surgical specialties are often involved in patient care, evaluation and management. The Scleroderma Service at Mayo Clinic in Arizona brings together physicians in scleroderma-related medical and surgical specialties to provide coordinated and comprehensive evaluation and treatment. The Scleroderma Service includes specialists from:
Benefits to being seen at the Scleroderma Service include:
Click here to make an appointment at the Scleroderma Service.